Proton Therapy / Medical Physics

• Huang HC, Chen HH, Lin CH, Kao WH, Hsiao IT, Chao TC. (Co-author)
  Comprehensive characterization of proton pencil beam profiles using a novel couch-mounted 2D strip detector system.
  Radiation Physics and Chemistry. 2025;232:112663.
  IF: 3.1
• Chen HH, Huang HC, Kao WH, Chen PJ, Hsiao IT, Chao TC. (Co-author)
  Rapid calibration curve generation using single-sheet radiochromic film for proton-based stereotactic radiosurgery verification.
  Radiation Physics and Chemistry. 2024;220:111631.
  IF: 3.1
• Hong JH, Kao WH, Shen YL. (Co-author)
  What are the potential benefits of using proton therapy in Taiwanese cancer patients?
  Biomedical Journal. 2015;38(5):391.
  IF: 3.7

Cancer Epidemiology / AYA Survivorship

• Kao WH, Chuang YF, Huang YW, Hsu RJ, Wang YH, Lin CC, et al. (First author)
  Adverse birth and obstetric outcomes in the offspring of male adolescent and young adult cancer survivors: A nationwide population-based study.
  Cancer Epidemiology, Biomarkers & Prevention. 2025;34(2):324-331.
  IF: 3.2
• Kao WH, Kuo CF, Chang CC, Sung FC, Muo CH, Tsai WC, et al. (First author)
  Cancer survivorship and risk of pregnancy complications, adverse obstetric outcomes, and maternal morbidities in female adolescents and young adults: A nationwide population-based study from Taiwan.
  British Journal of Cancer. 2023;129(3):503-510.
  IF: 9.1
• Kao WH, Kuo CF, Chiou MJ, Muo CH, Sung FC, Tsai WC, et al. (First author)
  Adverse birth outcomes in adolescent and young adult female cancer survivors: A nationwide population-based study.
  British Journal of Cancer. 2020;122(6):918-924.
  IF: 9.1

Clinical Radiation Oncology / Outcomes Research

• Chou YC, Wu YY, Hung SP, Lee CC, Chen YW, Hsu YH, Kao WH, et al. (Co-author)
  Treatment of primary central nervous system germinomas with short-course induction chemotherapy followed by low-dose radiotherapy without a tumor bed boost: Prognostic impact of human chorionic gonadotropin.
  Journal of Pediatric Hematology/Oncology. 2021;43(7):e907-e912.
  IF: 1.7
• Kao WH, Kuo CF, Chou IJ, Muo CH, Sung FC, Tsai WC, et al. (First author)
  Prostate-selective α-antagonists increase fracture risk in prostate cancer patients with and without a history of androgen deprivation therapy: A nationwide population-based study.
  Oncotarget. 2018;9(4):5263-5273.
  IF: 3.0 (historical)
• Kao WH, Hong JH, See LC, Yu CJ, Yang PC, et al. (First author)
  Validity of cancer diagnosis in the National Health Insurance database compared with the linked National Cancer Registry in Taiwan.
  Pharmacoepidemiology and Drug Safety. 2018;27(10):1060-1066.
  IF: 3.0
• Lin SY, Tsai CS, Chang YC, Huang EY, Hsu HC, Chen HC, Kao WH, et al. (Co-author)
  The role of pretreatment FDG-PET in treating cervical cancer patients with enlarged pelvic lymph node(s) shown on MRI: A phase 3 randomized trial with long-term follow-up.
  International Journal of Radiation Oncology Biology Physics. 2015;92(3):577-585.
  IF: 4.0
• Kao WH, Hong JH, Chao AN, Wang CC. (First author)
  Fractionated stereotactic radiotherapy for choroidal melanoma.
  放射治療與腫瘤學. 2014;21(3):191-199.
  IF: N/A